Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Indications/Uses

GLYXAMBI is indicated to improve glycaemic control in adults with type 2 diabetes mellitus: instead of empagliflozin, when diet, exercise and treatment with empagliflozin ± metformin do not provide adequate glycaemic control; instead of linagliptin, when diet, exercise and treatment with linagliptin ± metformin do not provide adequate glycaemic control.
GLYXAMBI can be used to replace the free combination of empagliflozin and linagliptin in adult patients with type 2 diabetes mellitus who are already being treated with this combination.

Glyxambi Indications/Uses

Manufacturer:

Boehringer Ingelheim

Distributor:

DKSH